Format

Send to

Choose Destination
J Neurol. 1992 Jul;239(6):299-301.

Second European Stroke Prevention Study. ESPS-2 Working Group.

[No authors listed]

Abstract

The computerized design, aims, organization, and structure of the European Stroke Prevention Study 2 (ESPS-2) are presented. This clinical trial will investigate the effect of single and combination regimens of low-dose acetylsalicylic acid (50 mg daily) and dipyridamole (400 mg daily) versus placebo in secondary prevention of stroke and death.

PMID:
1512604
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center